clinical trials for retatrutide retatrutide parkinson's trial Retatrutide, an experimental drug currently in Phase 3 clinical trials, is nicknamed Lilly's triple agonist, retatrutide, delivered
Pay in 4 interest-free payments of $6.87 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26





























